Vimarsana
Biggest News Aggregation in the World

Page 20 - Life Sciences Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Sciences Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Sciences Ltd Today - Breaking & Trending Today

Wave Life Sciences Ltd. (NASDAQ:WVE) Insider Chandra Vargeese Sells 16,714 Shares - Vimarsana News

Wave Life Sciences Ltd. (NASDAQ:WVE) Insider Chandra Vargeese Sells 16,714 Shares

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Tiziana Life Sciences Ltd.: Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference - Vimarsana News

Tiziana Life Sciences Ltd.: Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference

NEW YORK, April 26, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd (NASDAQ: TLSA) ("Tiziana" or the "Company"), a clinical-stage biopharmaceutical company developing alternative routes of immunotherapy

Tiziana Life Sciences to participate in a Fireside Chat At - Vimarsana News

Tiziana Life Sciences to participate in a Fireside Chat At

NEW YORK, April 26, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd (NASDAQ: TLSA) ("Tiziana" or the "Company"), a clinical-stage biopharmaceutical...

Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference - Vimarsana News

Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference

Tiziana Life Sciences Ltd (NASDAQ: TLSA) ("Tiziana" or the "Company"), a clinical-stage biopharmaceutical company developing alternative routes of immunotherapy with a focus on innovative drugs for neurodegenerative diseases, including treatment with intranasal foralumab for Secondary Progressive Multiple Sclerosis ...

Wave Life Sciences Ltd. (NASDAQ:WVE) Expected to Announce Quarterly Sales of $3.75 Million - Vimarsana News

Wave Life Sciences Ltd. (NASDAQ:WVE) Expected to Announce Quarterly Sales of $3.75 Million

Equities analysts predict that Wave Life Sciences Ltd. (NASDAQ:WVE – Get Rating) will post sales of $3.75 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Wave Life Sciences’ earnings. The highest sales estimate is $5.50 million and the lowest is $2.00 million. The firm is scheduled […]